Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeanne Burkart
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (ALLO) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients With Hematologic Malignancies: A Monocenter Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS
Bone Marrow Transplantation
Transplantation
Hematology
The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation?
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Thiotepa and Fractionated TBI Conditioning Prior to Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies: A Phase II Single Institution Trial
Bone Marrow Transplantation
Transplantation
Hematology
Myeloablative Conditioning for Hematopoietic Stem-Cell Transplantation in Patients With Non-Malignant Diseases
Bone Marrow Transplantation
Transplantation
Hematology
Role of Conditioning Regimens in Pediatric Hematopoietic Stem Cell Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Long-Term Outcome of HLA-haploidentical Hematopoietic Stem Cell Transplantation Without in Vitro T-Cell Depletion Based on an FBCA Conditioning Regimen for Hematologic Malignancies
Bone Marrow Transplantation
Transplantation
Hematology
Hematopoietic Stem Cell Transplantation for Childhood Myeloid Malignancies After High-Dose Thiotepa, Busulfan and Cyclophosphamide
Bone Marrow Transplantation
Transplantation
Hematology
